Atomistry » Fluorine » PDB 5he2-5hti » 5hjs
Atomistry »
  Fluorine »
    PDB 5he2-5hti »
      5hjs »

Fluorine in PDB 5hjs: Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease

Enzymatic activity of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease

All present enzymatic activity of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease:
2.3.1.48;

Protein crystallography data

The structure of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease, PDB code: 5hjs was solved by G.Parthasarathy, D.Klein, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 32.46 / 1.72
Space group P 4 21 2
Cell size a, b, c (Å), α, β, γ (°) 125.007, 125.007, 92.339, 90.00, 90.00, 90.00
R / Rfree (%) 20.8 / 23.8

Other elements in 5hjs:

The structure of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease also contains other interesting chemical elements:

Chlorine (Cl) 2 atoms

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease (pdb code 5hjs). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 6 binding sites of Fluorine where determined in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease, PDB code: 5hjs:
Jump to Fluorine binding site number: 1; 2; 3; 4; 5; 6;

Fluorine binding site 1 out of 6 in 5hjs

Go back to Fluorine Binding Sites List in 5hjs
Fluorine binding site 1 out of 6 in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F301

b:74.2
occ:1.00
 F2 A:668301 0.0 74.2 1.0
C24 A:668301 1.3 73.7 1.0
F1 A:668301 2.1 77.7 1.0
F A:668301 2.1 72.8 1.0
C3 A:668301 2.4 68.8 1.0
C2 A:668301 2.7 65.3 1.0
O A:668301 2.8 74.0 1.0
C1 A:668301 3.0 65.3 1.0
CD1 A:LEU264 3.4 47.2 1.0
C4 A:668301 3.7 61.3 1.0
CE1 A:PHE90 3.8 48.3 1.0
CD2 A:LEU264 4.2 47.2 1.0
O1 A:668301 4.2 60.0 1.0
CG A:LEU264 4.3 47.7 1.0
C A:668301 4.4 63.7 1.0
CD1 A:PHE90 4.4 47.3 1.0
CG A:LEU167 4.4 47.5 1.0
CD1 A:LEU167 4.5 48.0 1.0
N A:668301 4.5 55.3 1.0
CZ A:PHE90 4.6 47.0 1.0
CD A:GLN260 4.7 48.3 1.0
C5 A:668301 4.8 51.2 1.0
CG A:GLN260 4.8 33.0 1.0
NE2 A:GLN260 4.9 39.4 1.0
O A:GLY166 4.9 46.0 1.0
CD2 A:LEU271 5.0 44.4 1.0
O A:ALA165 5.0 47.1 1.0

Fluorine binding site 2 out of 6 in 5hjs

Go back to Fluorine Binding Sites List in 5hjs
Fluorine binding site 2 out of 6 in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F301

b:72.8
occ:1.00
 F A:668301 0.0 72.8 1.0
C24 A:668301 1.3 73.7 1.0
F1 A:668301 2.1 77.7 1.0
F2 A:668301 2.1 74.2 1.0
C3 A:668301 2.4 68.8 1.0
O A:668301 2.7 74.0 1.0
C4 A:668301 2.8 61.3 1.0
O1 A:668301 2.8 60.0 1.0
CG A:GLN260 3.1 33.0 1.0
CD1 A:LEU264 3.5 47.2 1.0
CD A:GLN260 3.7 48.3 1.0
N A:668301 3.7 55.3 1.0
C1 A:668301 3.8 65.3 1.0
NE2 A:GLN260 4.2 39.4 1.0
OE1 A:GLN260 4.2 42.1 1.0
C2 A:668301 4.3 65.3 1.0
CG A:LEU264 4.4 47.7 1.0
CB A:GLN260 4.5 34.8 1.0
C5 A:668301 4.5 51.2 1.0
CG A:LEU167 4.7 47.5 1.0
CD2 A:HIS257 4.7 34.3 1.0
NE2 A:HIS257 4.7 33.9 1.0
C9 A:668301 4.8 53.4 1.0
CE2 A:PHE171 4.8 39.4 1.0
CD2 A:LEU264 4.9 47.2 1.0
C A:668301 4.9 63.7 1.0
O A:GLN260 4.9 41.1 1.0
CD2 A:PHE171 4.9 36.5 1.0
C A:GLN260 5.0 40.5 1.0

Fluorine binding site 3 out of 6 in 5hjs

Go back to Fluorine Binding Sites List in 5hjs
Fluorine binding site 3 out of 6 in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F301

b:77.7
occ:1.00
 F1 A:668301 0.0 77.7 1.0
C24 A:668301 1.3 73.7 1.0
F A:668301 2.1 72.8 1.0
F2 A:668301 2.1 74.2 1.0
C3 A:668301 2.4 68.8 1.0
C4 A:668301 2.8 61.3 1.0
CG A:LEU167 2.9 47.5 1.0
C1 A:668301 3.1 65.3 1.0
N A:668301 3.1 55.3 1.0
C5 A:668301 3.1 51.2 1.0
CD1 A:LEU167 3.2 48.0 1.0
CD2 A:LEU167 3.3 48.5 1.0
C2 A:668301 3.5 65.3 1.0
O A:668301 3.5 74.0 1.0
O1 A:668301 3.6 60.0 1.0
CB A:LEU167 4.2 42.5 1.0
CG A:GLN260 4.3 33.0 1.0
OE1 A:GLN260 4.3 42.1 1.0
CD A:GLN260 4.4 48.3 1.0
C9 A:668301 4.4 53.4 1.0
C6 A:668301 4.5 48.4 1.0
CA A:LEU167 4.5 42.6 1.0
C A:668301 4.5 63.7 1.0
CE2 A:PHE171 4.5 39.4 1.0
CD2 A:PHE171 4.6 36.5 1.0
N A:LEU167 4.9 43.6 1.0

Fluorine binding site 4 out of 6 in 5hjs

Go back to Fluorine Binding Sites List in 5hjs
Fluorine binding site 4 out of 6 in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 4 of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F301

b:63.6
occ:1.00
 F2 B:668301 0.0 63.6 1.0
C24 B:668301 1.3 62.2 1.0
F B:668301 2.1 66.5 1.0
F1 B:668301 2.1 60.3 1.0
C3 B:668301 2.4 59.8 1.0
C2 B:668301 2.8 54.0 1.0
C1 B:668301 2.9 56.2 1.0
O B:668301 3.0 65.6 1.0
C4 B:668301 3.6 53.5 1.0
CG B:LEU167 3.7 39.1 1.0
CD1 B:LEU167 3.8 38.6 1.0
CD1 B:LEU264 3.9 47.6 1.0
CD B:GLN260 4.2 44.3 1.0
CD2 B:LEU264 4.2 47.3 1.0
O1 B:668301 4.3 51.6 1.0
CG B:GLN260 4.3 31.3 1.0
O B:GLY166 4.3 36.0 1.0
NE2 B:GLN260 4.3 35.2 1.0
N B:668301 4.4 49.5 1.0
C B:668301 4.4 54.9 1.0
CE1 B:PHE90 4.4 41.6 1.0
CA B:LEU167 4.4 34.3 1.0
OE1 B:GLN260 4.5 34.1 1.0
CG B:LEU264 4.5 47.2 1.0
C5 B:668301 4.5 46.5 1.0
C B:GLY166 4.5 37.6 1.0
N B:LEU167 4.6 35.2 1.0
CB B:LEU167 4.6 34.1 1.0
CD2 B:LEU167 4.8 38.7 1.0

Fluorine binding site 5 out of 6 in 5hjs

Go back to Fluorine Binding Sites List in 5hjs
Fluorine binding site 5 out of 6 in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 5 of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F301

b:66.5
occ:1.00
 F B:668301 0.0 66.5 1.0
C24 B:668301 1.3 62.2 1.0
F1 B:668301 2.1 60.3 1.0
F2 B:668301 2.1 63.6 1.0
C3 B:668301 2.4 59.8 1.0
O B:668301 2.5 65.6 1.0
C4 B:668301 3.0 53.5 1.0
O1 B:668301 3.0 51.6 1.0
CG B:GLN260 3.1 31.3 1.0
CD1 B:LEU264 3.1 47.6 1.0
CD B:GLN260 3.7 44.3 1.0
C1 B:668301 3.7 56.2 1.0
CG B:LEU264 3.9 47.2 1.0
NE2 B:GLN260 4.0 35.2 1.0
N B:668301 4.1 49.5 1.0
C2 B:668301 4.1 54.0 1.0
CD2 B:LEU264 4.4 47.3 1.0
OE1 B:GLN260 4.4 34.1 1.0
CB B:GLN260 4.5 30.1 1.0
O B:GLN260 4.5 34.9 1.0
C B:GLN260 4.7 34.8 1.0
C5 B:668301 4.8 46.5 1.0
C B:668301 4.9 54.9 1.0
N B:VAL261 4.9 32.2 1.0
CD2 B:LEU271 4.9 32.6 1.0
NE2 B:HIS257 4.9 28.8 1.0

Fluorine binding site 6 out of 6 in 5hjs

Go back to Fluorine Binding Sites List in 5hjs
Fluorine binding site 6 out of 6 in the Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 6 of Identification of Lxrbeta Selective Agonists For the Treatment of Alzheimer'S Disease within 5.0Å range:
probe atom residue distance (Å) B Occ
B:F301

b:60.3
occ:1.00
 F1 B:668301 0.0 60.3 1.0
C24 B:668301 1.3 62.2 1.0
F B:668301 2.1 66.5 1.0
F2 B:668301 2.1 63.6 1.0
C3 B:668301 2.4 59.8 1.0
C4 B:668301 2.6 53.5 1.0
N B:668301 2.9 49.5 1.0
CG B:LEU167 3.2 39.1 1.0
C5 B:668301 3.2 46.5 1.0
O1 B:668301 3.2 51.6 1.0
C1 B:668301 3.4 56.2 1.0
CG B:GLN260 3.4 31.3 1.0
O B:668301 3.5 65.6 1.0
CD2 B:LEU167 3.5 38.7 1.0
CD B:GLN260 3.7 44.3 1.0
CD2 B:PHE171 3.8 27.7 1.0
CE2 B:PHE171 3.8 29.2 1.0
CD1 B:LEU167 3.8 38.6 1.0
OE1 B:GLN260 3.8 34.1 1.0
C9 B:668301 4.0 49.5 1.0
C2 B:668301 4.1 54.0 1.0
CB B:LEU167 4.3 34.1 1.0
NE2 B:GLN260 4.5 35.2 1.0
C B:668301 4.7 54.9 1.0
CA B:LEU167 4.7 34.3 1.0
C6 B:668301 4.7 46.3 1.0
CB B:GLN260 4.8 30.1 1.0

Reference:

S.J.Stachel, C.Zerbinatti, M.T.Rudd, M.Cosden, S.Suon, K.K.Nanda, K.Wessner, J.Dimuzio, J.Maxwell, Z.Wu, J.M.Uslaner, M.S.Michener, P.Szczerba, E.Brnardic, V.Rada, Y.Kim, R.Meissner, P.Wuelfing, Y.Yuan, J.Ballard, M.Holahan, D.J.Klein, J.Lu, X.Fradera, G.Parthasarathy, V.N.Uebele, Z.Chen, Y.Li, J.Li, A.J.Cooke, D.J.Bennett, M.T.Bilodeau, J.Renger. Identification and in Vivo Evaluation of Liver X Receptor Beta-Selective Agonists For the Potential Treatment of Alzheimer'S Disease. J.Med.Chem. V. 59 3489 2016.
ISSN: ISSN 0022-2623
PubMed: 27011007
DOI: 10.1021/ACS.JMEDCHEM.6B00176
Page generated: Thu Aug 1 09:52:49 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy